| Eureka Group Holdings Limited (EGH) ORDINARY FULLY PAID |
Real Estate |
$229 |
App 4E and FY25 Annual Report
|
21 Aug 2025 9:02AM |
$0.558 |
$0.540 |
fallen by
3.14%
|
|
EGH - Price-sensitive ASX Announcement
Full Release
Key Points
- EGH recorded a 12% increase in statutory net profit after tax, reaching $8.1 million.
- EBITDA increased by 20% to $19.4 million for the year ended 30 June 2024.
- Growth was driven by higher occupancy rates, rental increases, and effective management within the affordable seniors’ rental accommodation market.
- Four new acquisitions were completed, expanding EGH’s property portfolio.
- The company’s balance sheet was further strengthened, supporting ongoing and future development projects.
- A fully franked final dividend of 0.67 cents per share was declared, reflecting consistent shareholder returns.
- Positive outlook based on expected continued rental growth and strategic investments in acquisitions and developments.
- EGH is positioned as a leading provider of affordable seniors’ rental accommodation in Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$11,921 |
Dividend/Distribution - SHL
|
21 Aug 2025 9:01AM |
$28.740 |
$24.120 |
fallen by
16.08%
|
|
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$45 |
Appendix 4G & Corporate Governance Statement
|
21 Aug 2025 9:00AM |
$0.340 |
$0.340 |
fallen by
0%
|
|
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$5,602 |
Board Appointment - Mr Brendan Pearson
|
21 Aug 2025 9:00AM |
$6.430 |
$6.730 |
risen by
4.67%
|
|
| Alliance Aviation Services Limited (AQZ) ORDINARY FULLY PAID |
Industrials |
$393 |
Correction to FY2025 Full Year Results Presentation
|
21 Aug 2025 9:00AM |
$2.580 |
$2.440 |
fallen by
5.43%
|
|
| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$755 |
GRES Appointment Strengthens Colosseum Feasibility Study
|
21 Aug 2025 8:59AM |
$0.210 |
$0.235 |
risen by
11.90%
|
|
| IDT Australia Limited (IDT) ORDINARY FULLY PAID |
Health Care |
$30 |
FY25 Full Year Profit Results
|
21 Aug 2025 8:59AM |
$0.069 |
$0.070 |
risen by
1.45%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$26 |
Appendix 4G & Corporate Governance Statement
|
21 Aug 2025 8:59AM |
$0.540 |
$0.570 |
risen by
5.56%
|
|
| Centuria Industrial REIT (CIP) ORDINARY UNITS FULLY PAID |
Real Estate |
$2,178 |
Update - Notification of buy-back - CIP
|
21 Aug 2025 8:58AM |
$3.390 |
$3.430 |
risen by
1.18%
|
|
| Qube Holdings Limited (QUB) ORDINARY FULLY PAID |
Industrials |
$7,501 |
Investor Presentation - 2025 Full Year Results
|
21 Aug 2025 8:58AM |
$4.500 |
$4.240 |
fallen by
5.78%
|
|
QUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Record FY25 underlying revenue, EBITDA, and NPATA achieved
- Strong performance across Operating Division, Patrick Terminals, and Property
- Growth driven by increased container volumes, new contracts, and logistics activity
- Significant progress at Moorebank Logistics Park, with new tenants and development
- Disciplined capital allocation and focus on cost efficiency maintained
- Continued investment in digitalization and automation initiatives
- Commitment to sustainability and decarbonization targets
- Infrastructure improvements across port, rail, and logistics assets
- Positive financial outlook for FY26, with further expansion in logistics, rail, and property
- Steady dividend growth and robust balance sheet position
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tryptamine Therapeutics Limited (TYP) ORDINARY FULLY PAID |
Health Care |
$43 |
Landmark EEG Biomarker Agreement for Precision Psychiatry
|
21 Aug 2025 8:58AM |
$0.033 |
$0.031 |
fallen by
6.06%
|
|
TYP - Price-sensitive ASX Announcement
Full Release
Key Points
- Tryptamine Therapeutics Limited announced a collaboration with MindBio Therapeutics Corp.
- The agreement grants TYP access to MindBio’s EEG Brain Mapping AI Biomarker Platform.
- This technology helps predict patient responses to psychedelic medicines using EEG data and AI analysis.
- TYP will use the biomarker platform in its precision psychiatry clinical programs.
- The partnership aims to enable more personalized and effective mental health treatments.
- Integrating AI-powered biomarkers is expected to optimize clinical trial success and accelerate therapy delivery.
- The collaboration signifies TYP’s strategic focus on innovation and advanced neurotechnology in mental healthcare.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$4,929 |
FY25 Results Presentation
|
21 Aug 2025 8:57AM |
$6.930 |
$7.340 |
risen by
5.92%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Downer EDI Limited delivered resilient financial results in FY25, with revenue growth driven by core urban services operations.
- The company improved cash conversion and reduced its net debt position compared to the previous period.
- Strategic priorities included the divestment of non-core assets, simplification of the business, and rebalancing of the cost base.
- Downer emphasized a customer-centric approach, safety enhancements, and ongoing sustainability efforts.
- A robust pipeline of projects supports the company's steady performance outlook for FY25.
- Operational discipline and transformation initiatives remain key focus areas for continued improvement.
- The presentation provides an overview of risks, governance structures, and leadership changes during the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$72 |
MVP Announces FY25 Full Year Results
|
21 Aug 2025 8:57AM |
$0.635 |
$0.635 |
fallen by
0%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Medical Developments International Limited (MVP) announced its full-year results for FY25.
- Revenue for the year was reported at $22.9 million, with a net loss after tax of $7.5 million.
- The company experienced growth in its Penthrox business, with international sales increasing due to new market entries and expansion in existing markets.
- Domestic sales were impacted by ongoing challenges in the Australian market, including regulatory delays and competitive pressures.
- MVP invested in research and development, regulatory submissions, and clinical trials to support pipeline products and expand Penthrox indications.
- Operating expenses increased due to higher investment in commercialization activities, international expansion, and regulatory costs.
- The company highlighted progress in its partnership strategies, including collaborations with major pharmaceutical companies for global distribution.
- Cash reserves were managed through a combination of capital raising and operational cost controls.
- The outlook for FY26 includes continued focus on international market expansion, product innovation, and improving operational efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Naos Emerging Opportunities Company Limited (NCC) ORDINARY FULLY PAID |
Financials |
$27 |
Appendix 4G & Corporate Governance Statement
|
21 Aug 2025 8:57AM |
$0.340 |
$0.365 |
risen by
7.35%
|
|
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$72 |
FY25 Full Year Results
|
21 Aug 2025 8:57AM |
$0.635 |
$0.635 |
fallen by
0%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant revenue growth and improved financial performance in FY25.
- Focused strategy on core business areas, especially pain management and Penthrox.
- Reduction of net loss and improvement in operating margins.
- Disciplined cost management and supply chain optimization.
- Continued investment in regulatory submissions and international expansion.
- Management reiterated a clear vision for sustainable long-term shareholder value.
- Emphasis on innovation and operational excellence.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,520 |
NSR 2025 Results Presentation
|
21 Aug 2025 8:56AM |
$2.440 |
$2.530 |
risen by
3.69%
|
|
| Sonic Healthcare Limited (SHL) ORDINARY FULLY PAID |
Health Care |
$11,921 |
Preliminary Final Report
|
21 Aug 2025 8:56AM |
$28.740 |
$24.120 |
fallen by
16.08%
|
|
SHL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sonic Healthcare Limited reported increased revenues and profits for the year ended 30 June 2022.
- Strong COVID-19 testing volumes contributed significantly to financial performance, while base business volumes showed signs of recovery and growth.
- Strategic acquisitions in the laboratory and pathology sectors were completed in key markets.
- Ongoing investments were made in technology, infrastructure, and quality initiatives.
- The Board declared a final dividend for shareholders, underlining robust cash flows and financial position.
- Detailed financial statements, management analysis, and commentary on risks, strategy, and business outlook are provided.
- Corporate governance and compliance disclosures are included in the report.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Gateway Mining Limited (GML) ORDINARY FULLY PAID |
Materials |
$11 |
Trading Halt
|
21 Aug 2025 8:55AM |
$0.028 |
$0.028 |
fallen by
0%
|
|
GML - Price-sensitive ASX Announcement
Full Release
Key Points
- Gateway Mining Limited (GML) has requested a trading halt from the ASX.
- The trading halt is sought pending an announcement about a proposed capital raising.
- The trading halt will be effective from 29 May 2023.
- The halt will last until the earlier of the announcement being made or market open on 31 May 2023.
- The purpose of the halt is to ensure a fair and informed market.
- The company's request is in accordance with ASX Listing Rule 17.1.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$72 |
FY25 Full Year Results Investor Presentation
|
21 Aug 2025 8:55AM |
$0.635 |
$0.635 |
fallen by
0%
|
|
MVP - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 full year financial results show strong revenue growth and improved EBITDA.
- Pain Management segment, led by Penthrox, remains the primary growth driver.
- International market expansion, especially in Europe and Asia-Pacific, is progressing well.
- Investments continue in regulatory approvals, research, and new product development.
- Strategic partnerships and ongoing clinical trials support long-term growth.
- Supply chain and regulatory challenges remain but are being actively managed.
- Board commits to disciplined capital management and reinvestment in key business areas.
- Positive outlook for revenue growth and operational improvements in the coming year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Whitehaven Coal Limited (WHC) ORDINARY FULLY PAID |
Energy |
$5,602 |
Update - Notification of buy-back - WHC
|
21 Aug 2025 8:54AM |
$6.430 |
$6.730 |
risen by
4.67%
|
|
| Downer EDI Limited (DOW) ORDINARY FULLY PAID |
Industrials |
$4,929 |
FY25 Results Media Release
|
21 Aug 2025 8:54AM |
$6.930 |
$7.340 |
risen by
5.92%
|
|
DOW - Price-sensitive ASX Announcement
Full Release
Key Points
- Downer EDI Limited announced its FY25 Results Media Release on 13 June 2024.
- The company reported successful contract wins across core business sectors.
- Operational improvements and cost control remained a key focus for management.
- Downer is transitioning towards a more sustainable and resilient business model.
- Key sectors highlighted include Transport, Utilities, and Facilities.
- Market challenges and cost pressures were noted but addressed with strategic actions.
- Commitment to safety and performance culture was reaffirmed by leadership.
- The company's outlook is cautiously optimistic, targeting core operations and disciplined capital management.
- Continued emphasis on ESG (Environmental, Social, and Governance) initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$4 |
IRGS Gold Targets defined at Tanjil Bren & Walhalla South
|
21 Aug 2025 8:54AM |
$0.009 |
$0.010 |
risen by
11.11%
|
|
IMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Infinity Mining Limited (IMI) has advanced exploration at Tanjil Bren and Walhalla South in the Central Victorian Goldfields, confirming the presence of Intrusion-Related Gold System (IRGS) targets.
- A comprehensive review and analysis of recent and historical exploration data has led to the identification of several new gold targets with IRGS affinities.
- The Tanjil Bren project area contains multiple gold prospects, with geological similarities to the Fosterville and Costerfield gold deposits.
- Field mapping, sampling, and geochemical surveys have delineated areas of strong gold anomalism associated with intrusive-related alteration zones.
- The company has prioritized drill targets based on geochemical, geophysical, and structural criteria for further testing.
- Walhalla South has also shown significant potential with multiple gold prospects identified, supported by historical mining records and recent sampling results.
- IMI plans to undertake further fieldwork, including geophysics and drilling, to test the newly defined IRGS targets and refine their exploration models.
- The company highlights the potential for large-scale, high-grade gold mineralization in both project areas due to their geological setting and exploration results.
- Community engagement and compliance with regulatory frameworks are stated as ongoing priorities for the exploration programs.
- IMI reaffirms its commitment to systematic exploration to unlock value from these prospective gold projects in Victoria.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NAOS Small Cap Opportunities Company Limited (NSC) ORDINARY FULLY PAID |
Financials |
$45 |
Dividend/Distribution - NSC
|
21 Aug 2025 8:54AM |
$0.340 |
$0.340 |
fallen by
0%
|
|
| Charter Hall Group (CHC) STAPLED SECURITIES US PROHIBITED |
Real Estate |
$11,253 |
Appendix 4G
|
21 Aug 2025 8:53AM |
$22.820 |
$23.790 |
risen by
4.25%
|
|
| NAOS Ex-50 Opportunities Company Limited (NAC) ORDINARY FULLY PAID |
Financials |
$26 |
Dividend/Distribution - NAC
|
21 Aug 2025 8:53AM |
$0.540 |
$0.570 |
risen by
5.56%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
